3.41
price up icon0.29%   0.01
pre-market  Vorhandelsmarkt:  3.36   -0.05   -1.47%
loading
Schlusskurs vom Vortag:
$3.40
Offen:
$3.56
24-Stunden-Volumen:
12,715
Relative Volume:
1.48
Marktkapitalisierung:
$170.18M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-4.6451
EPS:
-0.7341
Netto-Cashflow:
-
1W Leistung:
-3.94%
1M Leistung:
+0.29%
6M Leistung:
-35.66%
1J Leistung:
-6.58%
1-Tages-Spanne:
Value
$3.3936
$3.57
1-Wochen-Bereich:
Value
$3.30
$3.68
52-Wochen-Spanne:
Value
$3.11
$6.4229

Genfit Adr Stock (GNFT) Company Profile

Name
Firmenname
Genfit Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
167
Name
Twitter
@genfit_pharma
Name
Nächster Verdiensttermin
2024-09-19
Name
Neueste SEC-Einreichungen
Name
GNFT's Discussions on Twitter

Vergleichen Sie GNFT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GNFT
Genfit Adr
3.41 170.18M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 66.76B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Genfit Adr Stock (GNFT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-12-20 Hochstufung H.C. Wainwright Neutral → Buy
2020-07-23 Hochstufung Stifel Hold → Buy
2020-06-25 Eingeleitet BofA/Merrill Underperform
2020-05-13 Herabstufung Kepler Buy → Reduce
2020-05-12 Herabstufung Barclays Overweight → Equal Weight
2020-05-12 Herabstufung H.C. Wainwright Buy → Neutral
2019-10-29 Bestätigt B. Riley FBR Buy
2019-06-25 Eingeleitet Stifel Hold
2019-04-24 Eingeleitet SVB Leerink Outperform
2019-04-22 Eingeleitet Barclays Overweight
Alle ansehen

Genfit Adr Aktie (GNFT) Neueste Nachrichten

pulisher
Apr 01, 2025

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading - TradingView

Apr 01, 2025
pulisher
Mar 28, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - TradingView

Mar 28, 2025
pulisher
Mar 27, 2025

European Equities Traded in the US as American Depositary Receipts Edge Higher in Thursday Trading - TradingView

Mar 27, 2025
pulisher
Mar 26, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading - TradingView

Mar 26, 2025
pulisher
Mar 24, 2025

European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - TradingView

Mar 24, 2025
pulisher
Mar 18, 2025

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - TradingView

Mar 18, 2025
pulisher
Mar 14, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Down for Week - TradingView

Mar 14, 2025
pulisher
Mar 06, 2025

European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading - TradingView

Mar 06, 2025
pulisher
Mar 05, 2025

European Equities Traded in the US as American Depositary Receipts Climb Higher in Wednesday Trading - TradingView

Mar 05, 2025
pulisher
Mar 03, 2025

European Equities Traded in the US as American Depositary Receipts Surge Higher in Monday Trading - TradingView

Mar 03, 2025
pulisher
Feb 28, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week - TradingView

Feb 28, 2025
pulisher
Feb 21, 2025

GENFIT annonce les résultats préliminaires de l’Offre de Rachat proposée aux porteurs d’OCEANEs 2025 et la Convocation de l’assemblée générale des porteurs d’OCEANEs 2025 - GlobeNewswire Inc.

Feb 21, 2025
pulisher
Feb 14, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Up 1% for Week - TradingView

Feb 14, 2025
pulisher
Feb 05, 2025

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading - TradingView

Feb 05, 2025
pulisher
Oct 09, 2024

European Equities Traded in the US as American Depositary Receipts Open Week Slightly Higher - MSN

Oct 09, 2024
pulisher
Oct 09, 2024

European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading - MSN

Oct 09, 2024
pulisher
Sep 26, 2024

European Equities Traded in the US as American Depositary Receipts Move Higher in Tuesday Trading - MSN

Sep 26, 2024
pulisher
Jun 10, 2024

GENFIT: Historic Milestone Achieved with U.S. FDA - GlobeNewswire

Jun 10, 2024
pulisher
Jun 30, 2023

Ipsen and GENFIT Announce Positive Results from Phase III ELATIVE trial of elafibranor in patients with primary biliary cholangitis, a rare cholestatic liver disease - Ipsen

Jun 30, 2023
pulisher
Dec 18, 2021

Ipsen und GENFIT schließen im Rahmen einer langfristigen globalen Partnerschaft eine exklusive Lizenzvereinbarung für Elafibranor ab, ein Phase-III-Asset, das für die Behandlung von primärer biliärer Cholangitis geprüft wird - Business Wire

Dec 18, 2021
pulisher
Dec 17, 2021

Ipsen and GENFIT Enter Into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-Term Global Partnership - Business Wire

Dec 17, 2021
pulisher
Jun 27, 2019

The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO - Yahoo Finance

Jun 27, 2019

Finanzdaten der Genfit Adr-Aktie (GNFT)

Es liegen keine Finanzdaten für Genfit Adr (GNFT) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Kapitalisierung:     |  Volumen (24h):